Enolase and Arrestin are Novel Nonmyelin Autoantigens in Multiple Sclerosis

Author： Forooghian Farzin   Cheung Roy   Smith W.   O’connor Paul   Dosch Hans-Michael  

Publisher： Springer Publishing Company

ISSN： 0271-9142

Source： Journal of Clinical Immunology, Vol.27, Iss.4, 2007-07, pp. : 388-396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Induced Stem Cells as a Novel Multiple Sclerosis Therapy

By  

Current Stem Cell Research & Therapy, Vol. 11, Iss. 4, 2016-05 ,pp. : 313-320

Bentham Science Publishers

Access to resources Recommend Favorite

Induced Stem Cells as a Novel Multiple Sclerosis Therapy

By  

Current Stem Cell Research & Therapy, Vol. 11, Iss. 4, 2016-03 ,pp. : 313-320

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple genes/multiple autoantigens role in type 1 diabetes

By Abiru Norio   Eisenbarth George  

Clinical Reviews in Allergy and Immunology, Vol. 18, Iss. 1, 2000-02 ,pp. : 27-40

Humana Press, Inc

Access to resources Recommend Favorite

Clinical relapses of multiple sclerosis are associated with 'novel' valleys in natural killer cell functional activity

By Kastrukoff L.F.   Lau A.   Wee R.   Zecchini D.   White R.   Paty D.W.  

Journal of Neuroimmunology, Vol. 145, Iss. 1, 2003-12 ,pp. : 103-114

Elsevier

Access to resources Recommend Favorite

Genetic analysis of multiple sclerosis

By Walsh E.C.   Guschwan-McMahon S.   Daly M.J.   Hafler D.A.   Rioux J.D.  

Journal of Autoimmunity, Vol. 21, Iss. 2, 2003-09 ,pp. : 111-116

Elsevier

Access to resources Recommend Favorite